Clinical Trial Update: Evaluation of Thoraflex in the Treatment of Aneurysm or Penetrating Ulcer of the Descending Thoracic Aorta [NA]

View source ↗

Summary

The clinical trial evaluating Thoraflex for thoracic aortic aneurysm or penetrating aortic ulcer has been withdrawn. Sponsor: Vascutek Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penetrating Aortic Ulcer
• Thoracic Aortic Aneurysm

Drugs mentioned

• Thoraflex

Snippet

Sponsor: Vascutek Ltd. | Conditions: Aortic Aneurysm, Thoracic, Penetrating Aortic Ulcers (PAUs) | NA | Status: WITHDRAWN